Clinical Trial Update: DAPPAR AF Dabigatran for Peri Procedural Anticoagulation During Radiofrequency Ablation of Atrial Fibrillation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update indicating completion of studies on peri-procedural dabigatran anticoagulation during radiofrequency ablation for atrial fibrillat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Pradaxa (dabigatran etexilate)

Snippet

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Conditions: Atrial Fibrillation | Phase 4 | Status: COMPLETED